Carolyn Henry Elected to
National Health Care Advisory Group
Carolyn Henry, DVM, MS, has been elected to the National Academies of Practice and the Veterinary Medicine Academy as a distinguished practitioner and fellow. Henry is a professor of veterinary oncology and interim associate dean of research and graduate studies for the College of Veterinary Medicine, interim associate director of research for the Ellis Fischel Cancer Center and faculty facilitator for the One Health/One Medicine Mizzou Advantage area. She will be inducted into the NAP during its annual meeting and forum in April in Alexandria, Va.
NAP is a nonprofit organization founded in 1981 to advise governmental bodies on our healthcare system. Distinguished practitioners and scholars are elected by their peers in 10 health professions: dentistry, medicine, nursing, optometry, osteopathic medicine, pharmacy, podiatric medicine, psychology, social work and veterinary medicine. The interdisciplinary group of healthcare practitioners and scholars works to influence national health policy and promote quality healthcare through cooperative advocacy, practice, education and research.
NAP fellows are chosen only after a rigorous selection process, and membership is limited in order to maintain the academy’s high standards.
“The NAP embodies the principles of One Health/One Medicine that are central to my professional goals,” Henry said. “I'm honored to be included amongst such a diverse and talented group and look forward to contributing my passion for One Health to their efforts toward shaping the research, education and public policy landscape in the U.S. and beyond our borders.”
Henry received her bachelor’s degree in animal science and biology from Eastern Kentucky University. She completed her veterinary studies and earned a master of science in small animal surgery and medicine at Auburn University. Board certified in oncology by the American College of Veterinary Internal Medicine since 1994, Henry served on the faculty at Washington State University from 1993 to 1997 before coming to MU.
As a veterinary oncologist, Henry is perhaps best known for her work in the area of bladder cancer. Although the disease is often caught in its early stages when it is curable, people who are diagnosed with late-stage disease have only a 15 percent five-year survival rate. In addition, aggressive therapies for bladder cancer often negatively affect quality of life for affected patients. Canine bladder cancer is analogous to late-stage disease in people, as this type of cancer is often very invasive before clinical signs are detected in dogs. Henry’s work has centered on biomarker evaluation for earlier detection of bladder cancer and improved therapies for patients with late-stage disease. Henry developed the chemotherapy protocol for canine bladder cancer that is considered the standard of care today. It was subsequently evaluated in a multi-institutional clinical trial led by MU. Henry will take part in the Expert Opinion Planning Session for the Comparative Oncology Research Initiative in Invasive Bladder Cancer at the Indiana University School of Medicine in February 2014.
In her role as the faculty facilitator for MU’s One Health/One Medicine Mizzou Advantage initiative, Henry focuses on fostering multidisciplinary research and education relating to translational medicine and the convergence of human and animal health. She is a member of the One Health Commission and is often an invited speaker, both nationally and internationally, on the topic of One Health. Her message in these lectures, and the goal of her professional career, is to improve the efficiency and applicability of medical discovery by exploring the comparative aspects of diseases that affect multiple species, choosing relevant companion animal models to learn more about human disease and conducting well-designed clinical trials for the benefit of human and companion animal patients.
Return to News and Events home